USE OF TUMOR NECROSIS FACTOR-A INHIBITORS IN RHEUMATOID ARTHRITIS: TOPICAL ASPECTS
The use of tumor necrosis factor (TNF) а inhibitors in combination with methotrexate remains the basic method for treating active rheumatoid arthritis (RA). This line in antirheumatic therapy is rapidly developing. A number of unsolved issues associated with the selection of patients (particularly a...
Saved in:
Main Authors: | E L Luchikhina, D E Karateev, Ye L Luchikhina, D E Karateyev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2008-12-01
|
Series: | Современная ревматология |
Online Access: | https://mrj.ima-press.net/mrj/article/view/192 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tumor necrosis factor-α inhibitors and their effects on cardiovascular risk factorsin patients with rheumatoid arthritis
by: O G Lineva, et al.
Published: (2010-02-01) -
The tumor necrosis factor-α inhibitor golimumab in the treatment of rheumatoid arthritis
by: Natalia Vladimirovna Chichasova
Published: (2014-12-01) -
Nimesulide in rheumatoid arthritis
by: E. L. Luchikhina
Published: (2015-06-01) -
Ihmor necrosis factor-a inhibitors and cardiovascular risk in rheumatoid arthritis
by: Tatiana Valentinovna Popkova, et al.
Published: (2012-12-01) -
THE PROBLEMS OF THE SAFETY OF THERAPY WITH TUMOR NECROSIS FACTOR-а INHIBITORS
by: Dmitry Evgenyevich Karateyev
Published: (2009-09-01)